Hims & Hers Health's Health的股票在获得家用实验室测试公司Trybe Labs后猛涨了20%。 Hims & Hers Health's stock jumps 20% after acquiring at-home lab testing firm Trybe Labs.

希姆斯和赫尔斯健康公司在宣布收购Trybe Labs的家庭实验室测试设施后, 股价升了20%以上. Hims & Hers Health Inc. saw its stock soar by over 20% after announcing the acquisition of an at-home lab testing facility, Trybe Labs. 此举使公司能够提供家庭验血,扩大其保健服务,并有可能促进低睾酮和更年期支助等领域的增长。 This move allows the company to offer at-home blood tests, expanding its health services and potentially boosting growth in areas like low testosterone and menopausal support. 预计该采购将在下一年推出,从而增强个性化保健选择。 The acquisition is expected to roll out over the next year, enhancing personalized healthcare options. 尽管库存激增,但一些分析家对该公司的高估值持谨慎态度。 Despite the stock surge, some analysts caution about the company's high valuation.